Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jan 19, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Salary Limitation on AHRQ FY2021 Grants, Cooperative Agreements, and Contracts
Agency for Healthcare Research and Quality
General Notices
- Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for RFA-DA-21-029, RFA-DA-21-030, and RFA-MH-21-145
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Mental Health - FDA - Mandatory Submission of the Federal Financial Report (FFR) in the Payment Management System Beginning January 1, 2021
Food and Drug Administration - Notice of NICHD Participation on PA-20-196 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Technical Assistance Webinar for NHLBI Hope for Sickle Cell Disease Challenge
National Heart, Lung, and Blood Institute - Notice of Pre-Application Webinar for Cellular Senescence Network (SenNet) RFAs: RFA-RM-21-008, RFA-RM-21-009, RFA-RM-21-010
Office of Strategic Coordination (Common Fund) - Request for Information (RFI): Inviting Comments and Suggestions on the Identification of Key Events in Autoimmune Diseases
National Institute of Allergy and Infectious Diseases - Request for Information (RFI): Solicitation of Input on Common Data Elements for Lower Limb Loss Research Standards
Eunice Kennedy Shriver National Institute of Child Health and Human Development - BRAIN Initiative: Request for Information (RFI) on Development and Dissemination of Human Brain Imaging Technologies
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Notice of Changes to Funding Opportunities
- Notice to Extend the Response Date for NOT-CA-21-018 "Request for Information (RFI) Regarding Opportunities for New National Programs at the National Cancer Institutes (NCI) Frederick National Laboratory for Cancer Research"
National Cancer Institute - Notice of Cancellation of the April 2021 Application Receipt Date for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed"
Food and Drug Administration - Clarification of Scientific Overlap Concerns in PAR-20-117 "Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)"
National Institute of General Medical Sciences - Notice of Change to Funding Opportunity Description to Clarify the Requirement for a Sustainability Plan in PAR-20-104 "Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed)"
National Institute of General Medical Sciences - Notice of Change to Funds Available and Anticipated Number of Awards for RFA-MH-21-140, "BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)"
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest (NOSI): Administrative Supplements for NCI Division of Cancer Biology Research Programs
National Cancer Institute - Notice of Special Interest (NOSI): KC Donnelly Externship (Admin Supp Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences - Notice of Special Interest (NOSI): Biophysical and Biomechanical Aspects of Embryonic Development (R21)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Funding Opportunities
- Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
National Institute on Drug Abuse
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
- NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
National Institute on Aging
National Center for Complementary and Integrative Health
National Institute on Alcohol Abuse and Alcoholism
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
National Heart, Lung, and Blood Institute
- NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
National Institute for Occupational Safety and Health
- Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional)
National Institute on Aging
- Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
National Institute of Environmental Health Sciences
- Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
National Institute of Environmental Health Sciences
- HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)
- HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed)
- HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed)
- HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional)
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Mental Health
- Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
National Eye Institute
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
- Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required
Food and Drug Administration
- HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required)
- HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) Eunice Kennedy Shriver National Institute of Child Health and Human Development
- HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Institute on Drug Abuse
- INTUIT-PC: Improving Nonsurgical Treatment of Urinary Incontinence among women in Primary Care: Dissemination and Implementation of PCOR Evidence (U18)
Agency for Healthcare Research and Quality
- Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)
National Center for Advancing Translational Sciences
- Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
National Center for Advancing Translational Sciences
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu.